Galza-Met Tablets 50/850 mg contain a combination of Vildagliptin and Metformin Hydrochloride, used for the management of type 2 diabetes mellitus when blood glucose is not adequately controlled by diet, exercise, or single antidiabetic therapy, works by enhancing insulin secretion, reducing hepatic glucose production, and improving insulin sensitivity, helping maintain stable blood sugar levels and better glycemic control, manufactured by CCL.
Dosage:
Usually taken once or twice daily with meals as prescribed by the physician, dosage should be individualized according to blood glucose levels and patient response, swallow the tablet whole with water.
Side Effects:
Common: nausea, diarrhea, headache, dizziness, abdominal discomfort,
Less common / serious: hypoglycemia when used with other antidiabetic medicines, liver enzyme elevation, allergic reactions, lactic acidosis (rare),
Precautions: use with caution in patients with kidney or liver impairment, avoid excessive alcohol intake, monitor blood glucose and liver function regularly.
